Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 16Oropharyngeal Neoplasms 10Nasopharyngeal Carcinoma 10Prostatic Neoplasms 7Laryngeal Neoplasms 6Rectal Neoplasms 5Mouth Neoplasms 5Hypopharyngeal Neoplasms 5Head and Neck Neoplasms 5Carcinoma 5Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nasopharyngeal Neoplasms 2Mesothelioma 2Epstein-Barr Virus Infections 2Carcinoma, Intraductal, Noninfiltrating 2Astrocytoma 2Anus Neoplasms 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomatitis 1Stomach Neoplasms 1

Interventions

Oxaliplatin 30Fluorouracil 23Capecitabine 19Nivolumab 17pembrolizumab 16Leucovorin 16Docetaxel 10Paclitaxel 9Drug Therapy 9Cisplatin 9Trastuzumab 8S 1 (combination) 8Specimen Handling 7trastuzumab deruxtecan 6fludarabine 6Cyclophosphamide 6Bevacizumab 6Magnetic Resonance Spectroscopy 5Biopsy 5zolbetuximab 4Radiotherapy 4Irinotecan 4Carboplatin 4zimberelimab 3sintilimab 3olaparib 3durvalumab 3atezolizumab 3aldesleukin 3XELOX 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Radiotherapy, Intensity-Modulated × 90 days × Clear all
NCT02381561 2026-04-13

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

National Cancer Institute (NCI)

Phase 1 Active not recruiting
19 enrolled
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡